Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα

In this study, we utilized human DNA topoisomerase IIα as a model target to outline a dynophore-based approach to catalytic inhibitor design. Based on MD simulations of a known catalytic inhibitor and the native ATP ligand analog, AMP-PNP, we derived a joint dynophore model that supplements the stat...

Full description

Bibliographic Details
Main Authors: Matej Janežič, Katja Valjavec, Kaja Bergant Loboda, Barbara Herlah, Iza Ogris, Mirijam Kozorog, Marjetka Podobnik, Simona Golič Grdadolnik, Gerhard Wolber, Andrej Perdih
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/24/13474
_version_ 1797503833438420992
author Matej Janežič
Katja Valjavec
Kaja Bergant Loboda
Barbara Herlah
Iza Ogris
Mirijam Kozorog
Marjetka Podobnik
Simona Golič Grdadolnik
Gerhard Wolber
Andrej Perdih
author_facet Matej Janežič
Katja Valjavec
Kaja Bergant Loboda
Barbara Herlah
Iza Ogris
Mirijam Kozorog
Marjetka Podobnik
Simona Golič Grdadolnik
Gerhard Wolber
Andrej Perdih
author_sort Matej Janežič
collection DOAJ
description In this study, we utilized human DNA topoisomerase IIα as a model target to outline a dynophore-based approach to catalytic inhibitor design. Based on MD simulations of a known catalytic inhibitor and the native ATP ligand analog, AMP-PNP, we derived a joint dynophore model that supplements the static structure-based-pharmacophore information with a dynamic component. Subsequently, derived pharmacophore models were employed in a virtual screening campaign of a library of natural compounds. Experimental evaluation identified flavonoid compounds with promising topoisomerase IIα catalytic inhibition and binding studies confirmed interaction with the ATPase domain. We constructed a binding model through docking and extensively investigated it with molecular dynamics MD simulations, essential dynamics, and MM-GBSA free energy calculations, thus reconnecting the new results to the initial dynophore-based screening model. We not only demonstrate a new design strategy that incorporates a dynamic component of molecular recognition, but also highlight new derivates in the established flavonoid class of topoisomerase II inhibitors.
first_indexed 2024-03-10T03:56:00Z
format Article
id doaj.art-d9e7b114d1e74972aed9ab20e7944e36
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T03:56:00Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-d9e7b114d1e74972aed9ab20e7944e362023-11-23T08:46:51ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-12-0122241347410.3390/ijms222413474Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIαMatej Janežič0Katja Valjavec1Kaja Bergant Loboda2Barbara Herlah3Iza Ogris4Mirijam Kozorog5Marjetka Podobnik6Simona Golič Grdadolnik7Gerhard Wolber8Andrej Perdih9National Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, SloveniaNational Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, SloveniaNational Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, SloveniaNational Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, SloveniaNational Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, SloveniaNational Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, SloveniaNational Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, SloveniaNational Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, SloveniaInstitute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2-4, 14195 Berlin, GermanyNational Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, SloveniaIn this study, we utilized human DNA topoisomerase IIα as a model target to outline a dynophore-based approach to catalytic inhibitor design. Based on MD simulations of a known catalytic inhibitor and the native ATP ligand analog, AMP-PNP, we derived a joint dynophore model that supplements the static structure-based-pharmacophore information with a dynamic component. Subsequently, derived pharmacophore models were employed in a virtual screening campaign of a library of natural compounds. Experimental evaluation identified flavonoid compounds with promising topoisomerase IIα catalytic inhibition and binding studies confirmed interaction with the ATPase domain. We constructed a binding model through docking and extensively investigated it with molecular dynamics MD simulations, essential dynamics, and MM-GBSA free energy calculations, thus reconnecting the new results to the initial dynophore-based screening model. We not only demonstrate a new design strategy that incorporates a dynamic component of molecular recognition, but also highlight new derivates in the established flavonoid class of topoisomerase II inhibitors.https://www.mdpi.com/1422-0067/22/24/13474human DNA topoisomerase IIαcatalytic inhibitorsdynophore modelsdrug designmolecular simulationscancer research
spellingShingle Matej Janežič
Katja Valjavec
Kaja Bergant Loboda
Barbara Herlah
Iza Ogris
Mirijam Kozorog
Marjetka Podobnik
Simona Golič Grdadolnik
Gerhard Wolber
Andrej Perdih
Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα
International Journal of Molecular Sciences
human DNA topoisomerase IIα
catalytic inhibitors
dynophore models
drug design
molecular simulations
cancer research
title Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα
title_full Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα
title_fullStr Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα
title_full_unstemmed Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα
title_short Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα
title_sort dynophore based approach in virtual screening a case of human dna topoisomerase iiα
topic human DNA topoisomerase IIα
catalytic inhibitors
dynophore models
drug design
molecular simulations
cancer research
url https://www.mdpi.com/1422-0067/22/24/13474
work_keys_str_mv AT matejjanezic dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia
AT katjavaljavec dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia
AT kajabergantloboda dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia
AT barbaraherlah dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia
AT izaogris dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia
AT mirijamkozorog dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia
AT marjetkapodobnik dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia
AT simonagolicgrdadolnik dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia
AT gerhardwolber dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia
AT andrejperdih dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia